265 related articles for article (PubMed ID: 27188932)
1. A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation.
Shuker N; Shuker L; van Rosmalen J; Roodnat JI; Borra LC; Weimar W; Hesselink DA; van Gelder T
Transpl Int; 2016 Nov; 29(11):1158-1167. PubMed ID: 27188932
[TBL] [Abstract][Full Text] [Related]
2. High Intrapatient Variability in Tacrolimus Exposure Is Not Associated With Immune-mediated Graft Injury After Liver Transplantation.
van der Veer MAA; Nangrahary N; Hesselink DA; Erler NS; Metselaar HJ; van Gelder T; Darwish Murad S
Transplantation; 2019 Nov; 103(11):2329-2337. PubMed ID: 30801539
[TBL] [Abstract][Full Text] [Related]
3. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure.
Sapir-Pichhadze R; Wang Y; Famure O; Li Y; Kim SJ
Kidney Int; 2014 Jun; 85(6):1404-11. PubMed ID: 24336032
[TBL] [Abstract][Full Text] [Related]
4. Combined Effect of Inter- and Intrapatient Variability in Tacrolimus Exposure on Graft Impairment Within a 3-Year Period Following Kidney Transplantation: A Single-Center Experience.
Stefanović NZ; Veličković-Radovanović RM; Danković KS; Mitić BP; Paunović GJ; Cvetković MB; Cvetković TP
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):749-760. PubMed ID: 32886348
[TBL] [Abstract][Full Text] [Related]
5. Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol.
Goldsmith PM; Bottomley MJ; Okechukwu O; Ross VC; Ghita R; Wandless D; Falconer SJ; Papachristos S; Nash P; Androshchuk V; Clancy M;
BMJ Open; 2017 Jul; 7(7):e016144. PubMed ID: 28756385
[TBL] [Abstract][Full Text] [Related]
6. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D
Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278
[TBL] [Abstract][Full Text] [Related]
7. Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart Transplant.
Shuker N; Bouamar R; Hesselink DA; van Gelder T; Caliskan K; Manintveld OC; Balk AH; Constantinescu AA
Exp Clin Transplant; 2018 Jun; 16(3):326-332. PubMed ID: 28969528
[TBL] [Abstract][Full Text] [Related]
8. High Tacrolimus Intrapatient Variability and Subtherapeutic Immunosuppression are Associated With Adverse Kidney Transplant Outcomes.
Mendoza Rojas A; Hesselink DA; van Besouw NM; Dieterich M; de Kuiper R; Baan CC; van Gelder T
Ther Drug Monit; 2022 Jun; 44(3):369-376. PubMed ID: 35394988
[TBL] [Abstract][Full Text] [Related]
9. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
Whalen HR; Glen JA; Harkins V; Stevens KK; Jardine AG; Geddes CC; Clancy MJ
Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation.
Taber DJ; Su Z; Fleming JN; McGillicuddy JW; Posadas-Salas MA; Treiber FA; Dubay D; Srinivas TR; Mauldin PD; Moran WP; Baliga PK
Transplantation; 2017 Dec; 101(12):2931-2938. PubMed ID: 28658199
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
12. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation.
Borra LC; Roodnat JI; Kal JA; Mathot RA; Weimar W; van Gelder T
Nephrol Dial Transplant; 2010 Aug; 25(8):2757-63. PubMed ID: 20190242
[TBL] [Abstract][Full Text] [Related]
13. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA
Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
[TBL] [Abstract][Full Text] [Related]
14. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
15. Defining a threshold for tacrolimus intra-patient variability associated with late acute cellular rejection in paediatric kidney transplant recipients.
Abu Bakar K; Mohamad NA; Hodi Z; McCulloch T; Williams A; Christian M; Key T; Kim JJ
Pediatr Nephrol; 2019 Dec; 34(12):2557-2562. PubMed ID: 31520127
[TBL] [Abstract][Full Text] [Related]
16. No Apparent Influence of Nonadherence on Tacrolimus Intrapatient Variability in Stable Kidney Transplant Recipients.
Gokoel SRM; Zwart TC; Moes DJAR; van der Boog PJM; de Fijter JW
Ther Drug Monit; 2020 Oct; 42(5):702-709. PubMed ID: 32941396
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center.
Michael M; Minard CG; Kale AS; Brewer ED
Pediatr Transplant; 2016 Feb; 20(1):49-58. PubMed ID: 26916966
[TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab induction with tacrolimus monotherapy in 25 pediatric renal transplant recipients.
Sung J; Barry JM; Jenkins R; Rozansky D; Iragorri S; Conlin M; Al-Uzri A
Pediatr Transplant; 2013 Dec; 17(8):718-25. PubMed ID: 24164824
[TBL] [Abstract][Full Text] [Related]
20. Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation.
Rozen-Zvi B; Schneider S; Lichtenberg S; Green H; Cohen O; Gafter U; Chagnac A; Mor E; Rahamimov R
Nephrol Dial Transplant; 2017 Feb; 32(2):393-399. PubMed ID: 28025383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
